The Advantage of Specific Intravenous Immunoglobulin (sIVIG) on Regular IVIG: Experience of the Last Decade
出版年份 2012 全文链接
标题
The Advantage of Specific Intravenous Immunoglobulin (sIVIG) on Regular IVIG: Experience of the Last Decade
作者
关键词
Specific IVIG, autoimmune diseases, inflammation, anti-myeloperoxidase, vasculitis
出版物
JOURNAL OF CLINICAL IMMUNOLOGY
Volume 33, Issue S1, Pages 27-32
出版商
Springer Nature
发表日期
2012-12-10
DOI
10.1007/s10875-012-9842-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Autoimmune blistering diseases of the skin
- (2011) Michael Sticherling et al. AUTOIMMUNITY REVIEWS
- Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in mice
- (2010) H.-S. Huang et al. BLOOD
- IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes
- (2010) J.-F. Seite et al. BLOOD
- Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris
- (2010) D. Mimouni et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis
- (2010) Revital Aricha et al. JOURNAL OF AUTOIMMUNITY
- A Novel Role for the IgG Fc Glycan: The Anti-inflammatory Activity of Sialylated IgG Fcs
- (2010) Robert M. Anthony et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Anti-phospholipid antibody mediated fetal loss: still an open question from a pathogenic point of view
- (2010) PL Meroni et al. LUPUS
- Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis
- (2009) Maria Giovanna Danieli et al. AUTOIMMUNITY REVIEWS
- Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin
- (2009) Caroline Galeotti et al. AUTOIMMUNITY REVIEWS
- Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection
- (2009) David Ben-Nathan et al. BMC INFECTIOUS DISEASES
- An ‘n-of-1’ placebo-controlled crossover trial of intravenous immunoglobulin as adjuvant therapy in refractory pemphigus vulgaris
- (2009) D.F. Arnold et al. BRITISH JOURNAL OF DERMATOLOGY
- Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation
- (2009) R. Schwartz-Albiez et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Evidence for the Use of Intravenous Immunoglobulins—A Review of the Literature
- (2009) Shaye Kivity et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Anti-vascular endothelial growth factor (VEGF) specific activity of intravenous immunoglobulin (IVIg)
- (2009) M. Damianovich et al. INTERNATIONAL IMMUNOLOGY
- A randomized double-blind trial of intravenous immunoglobulin for pemphigus
- (2009) Masayuki Amagai et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside
- (2009) G Zandman-Goddard et al. LUPUS
- Treatment of Myasthenia Gravis Acute Exacerbations with Intravenous Immunoglobulin
- (2008) Philippe Gajdos et al. Annals of the New York Academy of Sciences
- Anti-Inflammatory Actions of Intravenous Immunoglobulin
- (2008) Falk Nimmerjahn et al. Annual Review of Immunology
- Natural and disease associated anti-myeloperoxidase (MPO) autoantibodies
- (2008) Philippe Guilpain et al. AUTOIMMUNITY REVIEWS
- What is the contents of the magic draft IVIg?
- (2008) Jean-François Seite et al. AUTOIMMUNITY REVIEWS
- A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis
- (2008) Sara Fuchs et al. JOURNAL OF NEUROIMMUNOLOGY
- Identification of a receptor required for the anti-inflammatory activity of IVIG
- (2008) R. M. Anthony et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc
- (2008) R. M. Anthony et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started